Literature DB >> 7930626

Apoptotic cell death induced by intracellular proteolysis.

M S Williams1, P A Henkart.   

Abstract

To mimic the injection of granzymes into target cells by cytotoxic lymphocytes or the activation of endogenous proteases in programmed cell death, the proteases chymotrypsin, proteinase K, or trypsin were loaded into the cytoplasm of several different cell types using the osmotic lysis of pinosomes technique. Internalization of these proteases caused cell lysis within several hours, accompanied by extensive nuclear damage in most but not all combinations of target cells and proteases. This nuclear damage, quantitated by DNA release from nuclei, was associated with apoptotic features including DNA fragmentation into nucleosomal ladders, chromatin condensation, nuclear fragmentation, and membrane blebbing. Agents reported to block programmed cell death, including aurintricarboxylic acid, inhibitors of energy metabolism, and protein or RNA synthesis, failed to block this protease-induced death, although some inhibited nuclear damage. In separate experiments, introduction of staphylococcal nuclease into cells led to near complete (at least 75% of total) nucleosomal DNA fragmentation within 6 to 8 h. Condensation of chromatin did not accompany this fragmentation to the same extent, and there was approximately a 10-h lag between half-maximal DNA fragmentation and 50% loss of membrane integrity. The results suggest that activation of intracellular proteases during cell death by any molecular pathway could give rise to apoptotic morphology and DNA fragmentation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930626

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Non-caspase proteases: triggers or amplifiers of apoptosis?

Authors:  Karen Schrader; Jisen Huai; Lars Jöckel; Carolin Oberle; Christoph Borner
Journal:  Cell Mol Life Sci       Date:  2010-02-19       Impact factor: 9.261

2.  Requirements for proteolysis during apoptosis.

Authors:  D L Vaux; S Wilhelm; G Häcker
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Cathepsin B facilitates autophagy-mediated apoptosis in SPARC overexpressed primitive neuroectodermal tumor cells.

Authors:  P Bhoopathi; C Chetty; M Gujrati; D H Dinh; J S Rao; S Lakka
Journal:  Cell Death Differ       Date:  2010-03-26       Impact factor: 15.828

4.  Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.

Authors:  J J Yang; R Kettritz; R J Falk; J C Jennette; M L Gaido
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

5.  Activation of pro-caspase-7 by serine proteases includes a non-canonical specificity.

Authors:  Q Zhou; G S Salvesen
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

6.  Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function.

Authors:  M Higuchi; B B Aggarwal; E T Yeh
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

7.  Pivotal role of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways.

Authors:  L Dubrez; I Savoy; A Hamman; E Solary
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

8.  Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

Authors:  B B Gelman; D A Wolf; M Rodriguez-Wolf; A B West; A K Haque; M Cloyd
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

9.  Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B.

Authors:  L T Quan; M Tewari; K O'Rourke; V Dixit; S J Snipas; G G Poirier; C Ray; D J Pickup; G S Salvesen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

Review 10.  Protease signaling in animal and plant-regulated cell death.

Authors:  Guy S Salvesen; Anne Hempel; Nuria S Coll
Journal:  FEBS J       Date:  2015-12-31       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.